Israel’s BioView is pairing its imaging technology with fluorescent DNA markers to help doctors find this deadly cancer before it’s too late.
A new non-invasive test to aid in early detection of lung cancer may soon be available, thanks to an agreement between Israel’s BioView and a leading California laboratory.

bioview-device: If a certain percentage of the cells show abnormal fluorescent patterns, that indicates lung cancer.
The test involves analyzing a patient’s sputum (phlegm) using BioView’s scanning-microscope imaging equipment and fluorescent DNA markers called FISH probes. BioView licensed these markers from MD Anderson Cancer Center in Houston, Texas. Continue Reading »












Israeli New Shekel Exchange Rate